A

Alcanza Clinical Research

Inclusive clinical trials for diverse patients

Overview

Alcanza Clinical Research conducts inclusive clinical trials by partnering with pharmaceutical companies, medical providers, and community organizations to enroll diverse patient populations across major therapeutic areas. Its studies follow established protocols with certified research professionals to ensure patient safety and data integrity, while participants may receive health tests and access to emerging treatments at no cost. The company differentiates itself through active community collaboration, broad patient diversity, and education alongside trial execution, expanding trial reach. Its goal is to speed the development of new therapies by removing participation barriers and delivering high-quality, diverse clinical research.

Work here?Claim your company

About Alcanza Clinical Research

Simplify's Rating
Why Alcanza Clinical Research is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Lake Mary, FL

Founded

2021

Get referred to Alcanza Clinical Research

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • June 2026 CNS Healthcare expanded Alcanza’s network and improved access in Tennessee and Florida.
  • May 2026 Enspire and April 2026 Phoenix openings broadened early-stage capacity and regional reach.
  • June 18, 2026 CIO Jim Leary strengthens data systems, which sponsors reward with faster enrollment.

What critics are saying

  • The January 2026 TTAB loss against Diversa proves Alcanza’s branding defenses remain fragile.
  • June 2026 CNS integration can distract operations, delay startup timelines, and dilute site-level execution.
  • Sponsor demand depends on pharma trial budgets; a major protocol-mix slowdown would hit utilization fast.

What makes Alcanza Clinical Research unique

  • Alcanza built a multi-site network across Tennessee, Florida, Illinois, Arizona, and Nevada by June 2026.
  • Its patient-centric, inclusive trial model pairs community partnerships with onsite labs and mobile capabilities.
  • The CNS Healthcare acquisition added neuroscience and behavioral-health depth plus five established locations.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

Alcanza Clinical Research is Hiring for 45 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs